Dupilumab for treating severe asthma with type 2 inflammation

Supporting evidence

• Evaluation report

• Appraisal consultation 1 committee papers (PDF 4.31 MB)

  Published:

  08 December 2021

• Appraisal consultation 2 committee papers (PDF 1.4 MB)

  Published:

  08 December 2021

• Final appraisal determination committee papers (PDF 1.49 MB)

  Published:

  08 December 2021